These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25815206)

  • 41. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
    van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
    Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study.
    Bonnet F; Marre M; Halimi JM; Stengel B; Lange C; Laville M; Tichet J; Balkau B;
    J Hypertens; 2006 Jun; 24(6):1157-63. PubMed ID: 16685216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and characterization of some atypical sphingoid bases.
    Saied EM; Le TL; Hornemann T; Arenz C
    Bioorg Med Chem; 2018 Aug; 26(14):4047-4057. PubMed ID: 29960730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry.
    Sriboonvorakul N; Pan-Ngum W; Poovorawan K; Winterberg M; Tarning J; Muangnoicharoen S
    Int Health; 2021 Jul; 13(4):367-373. PubMed ID: 33118019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1-Deoxysphingolipids and Their Analogs in Foods: The Occurrence and Potential Impact on Human Health.
    Hu Z; Duan J
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(Supplement):S146-S148. PubMed ID: 36437001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy.
    Kramer R; Bielawski J; Kistner-Griffin E; Othman A; Alecu I; Ernst D; Kornhauser D; Hornemann T; Spassieva S
    FASEB J; 2015 Nov; 29(11):4461-72. PubMed ID: 26198449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
    Othman A; Benghozi R; Alecu I; Wei Y; Niesor E; von Eckardstein A; Hornemann T
    J Clin Lipidol; 2015; 9(4):568-75. PubMed ID: 26228675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Islet β-cell failure in type 2 diabetes--Within the network of toxic lipids.
    Janikiewicz J; Hanzelka K; Kozinski K; Kolczynska K; Dobrzyn A
    Biochem Biophys Res Commun; 2015 May; 460(3):491-6. PubMed ID: 25843796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elucidating the chemical structure of native 1-deoxysphingosine.
    Steiner R; Saied EM; Othman A; Arenz C; Maccarone AT; Poad BL; Blanksby SJ; von Eckardstein A; Hornemann T
    J Lipid Res; 2016 Jul; 57(7):1194-203. PubMed ID: 27165858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
    Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
    Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma.
    Duan J; Merrill AH
    J Biol Chem; 2015 Jun; 290(25):15380-15389. PubMed ID: 25947379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability.
    Nishio S; Abe M; Ito H
    Diabetes Metab Syndr Obes; 2015; 8():163-71. PubMed ID: 25834461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serine Metabolism in Health and Disease and as a Conditionally Essential Amino Acid.
    Holeček M
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. L-Serine Deficiency Elicits Intracellular Accumulation of Cytotoxic Deoxysphingolipids and Lipid Body Formation.
    Esaki K; Sayano T; Sonoda C; Akagi T; Suzuki T; Ogawa T; Okamoto M; Yoshikawa T; Hirabayashi Y; Furuya S
    J Biol Chem; 2015 Jun; 290(23):14595-609. PubMed ID: 25903138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of cellular and systemic sphingolipid homeostasis.
    Kuo A; Hla T
    Nat Rev Mol Cell Biol; 2024 Oct; 25(10):802-821. PubMed ID: 38890457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceramides are fuel gauges on the drive to cardiometabolic disease.
    Wilkerson JL; Tatum SM; Holland WL; Summers SA
    Physiol Rev; 2024 Jul; 104(3):1061-1119. PubMed ID: 38300524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deoxysphingolipids: Atypical Skeletal Muscle Lipids Related to Insulin Resistance in Humans That Decrease Insulin Sensitivity In Vitro.
    Zarini S; Zemski Berry KA; Kahn DE; Garfield A; Perreault L; Kerege A; Bergman BC
    Diabetes; 2023 Jul; 72(7):884-897. PubMed ID: 37186949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury.
    Gai Z; Samodelov SL; Alecu I; Hornemann T; Grove JI; Aithal GP; Visentin M; Kullak-Ublick GA
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Impaired Glycolysis in Perturbations of Amino Acid Metabolism in Diabetes Mellitus.
    Holeček M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.
    Di Pietro P; Izzo C; Abate AC; Iesu P; Rusciano MR; Venturini E; Visco V; Sommella E; Ciccarelli M; Carrizzo A; Vecchione C
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.